| abstract |
The invention relates to agents and methods for the diagnosis and therapy of cancer and further to the identification of cancer associated marker. The following tumor marker were identified: Q14259 Enhancer of rudimentary homolog, O00151 PDZ and LIM Domain Protein 1, P55072 Transitional Endolasmatic Reticulum ATPase, P47756 F-Actin Capping Protein Beta subunit, P11021 78 kDa Glucose regulated protein precursor, Q9Y4L1 150 kD Oxygen-regulated Protein Precursor. |